Clinical Trial Update: Omnifit Hydroxylapatite (HA) Hip Outcomes Study [NA]

View source ↗

Summary

The Omnifit Hydroxylapatite Hip Outcomes Study sponsored by Stryker Orthopaedics was terminated, and results were posted in August 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• Omnifit Hydroxylapatite Hip Implant

Snippet

Sponsor: Stryker Orthopaedics | Conditions: Arthroplasty, Replacement, Hip | NA | Status: TERMINATED | Results posted: 2014-08-19